Ebola outbreak in Democratic Republic of Congo claims over 2,000 lives

The death toll from the Ebola outbreak in the Democratic Republic of Congo has surpassed 2,011 fatalities, according to the latest official data, raising concerns that this could become the deadliest epidemic in the country’s history. Government records released overnight confirmed 4,381 confirmed cases nationwide.

The acceleration is stark: while the first 1,000 deaths accumulated over nine weeks, the second thousand were recorded in just three weeks—a clear indicator that the health crisis is outpacing containment and response efforts.

Critical obstacles include rebel violence, deteriorating road infrastructure, and healthcare worker strikes stemming from unpaid wages, severely hampering the delivery of medical aid to remote regions.

Dr. Jean-Marie Akandabo, overseeing patient care at a local clinic in Ituri (northeastern DRC), described the situation as “alarming” and urgently called for intensified intervention in affected areas.

This marks the 17th outbreak of the highly contagious disease in the country, already the largest in DRC history. “This epidemic could well become the largest ever recorded”, warned Sania Nishtar, CEO of Gavi, the global vaccine alliance.

The current case fatality rate stands at 45.9%, significantly higher than the 39.6% recorded during the devastating 2014–2016 West Africa outbreak, which claimed over 11,000 lives from 28,000 cases—a benchmark no other Ebola outbreak has surpassed.

Public health emergency declared

Officially declared on May 15, genomic analysis reveals the outbreak likely began months earlier, in February. The DRC government has since declared a public health emergency.

Unlike prior outbreaks, this epidemic is caused by the rare Bundibugyo strain, for which no approved vaccines or treatments currently exist. Clinical trials have begun in Ituri Province, the outbreak’s epicenter in eastern Congo.

Healthcare workers report the epidemic continues to outpace the response across the five eastern provinces affected. Many medical staff have gone on strike to protest unpaid wages since the outbreak was declared. The World Health Organization notes that most new cases are being detected outside monitored contact tracing chains, indicating transmission remains uncontrolled.

“Without an effective vaccine, containment relies entirely on early case identification and secure isolation until recovery or, tragically, death”, explained Paul Hunter, professor of medicine at the University of East Anglia, UK. “In a conflict-ridden, remote region with disrupted communication networks, routine surveillance becomes nearly impossible—and early detection to prevent spread may be unattainable.”

On Friday, WHO vaccine experts recommended launching a large-scale human trial with the only currently licensed Ebola vaccine to assess potential cross-protection against the Bundibugyo strain currently spreading in DRC—a strain for which no specific vaccine exists.

Ervebo has proven safe and effective against the Zaire strain, the most common Ebola variant. Preliminary data, including animal studies, suggest it may offer some protection against the Bundibugyo strain driving the current outbreak.

Two candidate vaccines for the Bundibugyo strain are in early human trial phases, with a third undergoing development for initial testing.

Dr. Mohamed Yakub Janabi, WHO Regional Director for Africa, emphasized that officials are “running after the virus, which is always one step ahead.”

Ebola spreads through bodily fluids and causes severe hemorrhagic fever. First identified in 1976 near the Ebola River in what is now the Democratic Republic of Congo, the virus remains one of the deadliest known to humanity.